European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Expected publication dates of PRAC recommendations on safety signals
Withdrawn application: Vectra 3D, 27/11/2024
Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn
2009 (H1N1) influenza pandemic
Pandemic influenza
Vaccines for pandemic influenza
Human medicines European public assessment report (EPAR): Refixia, nonacog beta pegol, Date of authorisation: 02/06/2017, Revision: 8, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Vaxxitek HVT+IBD+H5, avian influenza vaccine (live recombinant), Status: Authorised
EMA workshop on the challenges in drug development, regulation and clinical practice for immunoglobulins, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 March 2025, 14:00 (CET) to 5 March 2025, 18:00 (CET)